Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the American College of Cardiology

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(98)00375-1PMID 9809945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of different compression therapies on the reflux in deep veins with a post-thrombotic syndrome.

  1999cited by this paper
• Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.

  1998cited by this paper
• Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin.

  1997cited by this paper
• Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.

  1997influential reference
• Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine.

  1997cited by this paper
• Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.

  1997cited by this paper
• Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.

  1997cited by this paper
• Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study.

  1997cited by this paper
• L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle.

  1997cited by this paper
• Regression or progression. Dependency on vascular nitric oxide.

  1996cited by this paper
• Exercise Rehabilitation Programs for the Treatment of Claudication Pain: A Meta-Analysis

  1996cited by this paper
• Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.

  1996cited by this paper
• URINARY NO3− EXCRETION AS AN INDICATOR OF NITRIC OXIDE FORMATION IN VIVO DURING ORAL ADMINISTRATION OF l‐ARGININE OR l‐NAME IN RATS

  1996cited by this paper
• The Pentoxifylline Experience: Exercise Testing Reconsidered

  1996cited by this paper
• TOWARDS OPTIMIZATION OF WAVE REFLECTION: THERAPEUTIC GOAL FOR TOMORROW?

  1996cited by this paper
• L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.

  1996influential reference
• Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits.

  1996cited by this paper
• The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease.

  1995cited by this paper
• Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

  1995cited by this paper
• Exercise Rehabilitation Programs for the Treatment of Claudication Pain: A Meta-analysis

  1995cited by this paper
• Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

  1995cited by this paper
• Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.

  1995cited by this paper
• Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production.

  1995influential reference
• Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

  1995cited by this paper
• L-arginine reverses the impairment of nitric oxide-dependent collateral perfusion in dietary-induced hypercholesterolaemia in the rabbit.

  1994cited by this paper
• Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.

  1994cited by this paper
• Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs.

  1994cited by this paper
• Second European Consensus Document on Chronic Critical Limb Ichaemia.

  1993cited by this paper
• The L-arginine: nitric oxide pathway.

  1993cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.

  1992cited by this paper
• Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

  1992cited by this paper
• EDRF plays central role in collateral flow after arterial occlusion in rabbit ear.

  1992cited by this paper
• Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

  1992cited by this paper
• Color and conventional image‐directed Doppler ultrasonography: Accuracy and sources of error in quantitative blood flow measurements

  1992cited by this paper
• L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

  1992cited by this paper
• Analgesic effect of L-arginine in patients with persistent pain.

  1991cited by this paper
• Roles of P2‐Purinoceptors in the Cardiovascular System

  1991cited by this paper
• The ratio of ankle and arm arterial pressure as an independent predictor of mortality.

  1991cited by this paper
• Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta

  1991cited by this paper
• Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine.

  1991cited by this paper
• Characterization of the l‐arginine: nitric oxide pathway in human platelets

  1990cited by this paper
• Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.

  1990cited by this paper
• Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis.

  1990cited by this paper
• Therapeutic efficacy of intravenously applied prostaglandin E1.

  1989cited by this paper
• Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans.

  1989cited by this paper
• Effect of prostaglandin E1 upon collateral vessels in peripheral occlusive arterial disease.

  1989cited by this paper
• Selective Attenuation of Endothelium‐Mediated Vasodilation in Atherosclerotic Human Coronary Arteries

  1988cited by this paper
• Inborn errors of the urea cycle.

  1987cited by this paper
• Intermittent claudication: not so benign.

  1986cited by this paper
• Anaphylactic reaction to arginine infusion.

  1973cited by this paper
• Anaphylactic reaction to arginine infusion.

  1973cited by this paper

• Promotion of nitric oxide production: mechanisms, strategies, and possibilities

  2025cites this paper
• Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study).

  2025cites this paper
• Applications of L-Arginine in Pregnancy and Beyond: An Emerging Pharmacogenomic Approach.

  2024cites this paper
• A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS

  2023cites this paper
• Transport of nitrite from large arteries modulates regional blood flow during stress and exercise

  2023cites this paper
• Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome

  2023cites this paper
• The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19

  2022cites this paper
• New perspectives for investigating muscular perfusion response after dietary supplement intake: an exploratory, randomized, double-blind, placebo-controlled crossover trial in healthy young athletes using contrast-enhanced ultrasound (CEUS)

  2022cites this paper
• Nitric oxide, aging and aerobic exercise: Sedentary individuals to Master's athletes.

  2022cites this paper
• Improved Vascular Function and Functional Capacity Following L-Citrulline Administration in Patients with HFpEF: A Single-arm, Open-label Pilot Study.

  2022cites this paper
• A Paradoxical Vasodilatory Nutraceutical Intervention for Prevention and Attenuation of Migraine—A Hypothetical Review

  2020cites this paper
• A nanoscopic explanation of nitric oxide solubility in natural deep eutectic solvents

  2020cites this paper
• The effect of oral L-arginine supplementation on asymmetric dimethylarginine levels: A systematic review and meta-analysis of randomized clinical trials

  2020cites this paper
• Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension

  2020cites this paper
• The Use of L-arginine Supplements for Cardiovascular Disease and Related Disorders is Questionable

  2020cites this paper
• Stanowisko polskich ekspertów dotyczące leczenia zachowawczego u pacjentów z chorobą tętnic kończyn dolnych

  2019cites this paper
• The position of Polish experts on conservative management in patients with artery diseases of lower limbs

  2019cites this paper
• End-organ dysfunction in peripheral arterial disease - it is all about the skeletal muscle microvasculature.

  2018cites this paper
• The clinical effects of l‐arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon

  2018cites this paper
• Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells

  2018cites this paper
• Prognostic efficacy of circulating asymmetric dimethylarginine in patients with peripheral arterial disease: A meta-analysis of prospective cohort studies

  2018cites this paper
• Nitric oxide donors for peripheral artery disease

  2018cites this paper
• Targeting Complications of Diabetes with Antioxidants

  2017cites this paper
• Targeting vascular (endothelial) dysfunction

  2017cites this paper
• The l-Arginine/Asymmetric Dimethylarginine (ADMA) Ratio in Health and Disease: An Overview

  2017cites this paper
• The LargPAD Trial: Phase IIA evaluation of l‐arginine infusion in patients with peripheral arterial disease

  2017cites this paper
• “The Nutraceutical Amino Acids”- Nature’s Fortification for Robust Health

  2016cites this paper
• Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus

  2016cites this paper
• l-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women

  2016cites this paper
• Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans.

  2015cites this paper
• Understanding the role of antioxidant therapy for intermittent claudication; good, bad, or both?

  2015cites this paper
• Assessing Functional Vasodilation in the Gracilis Collateral Arteriole

  2015cites this paper
• Kapitel 4 – Erkrankungen des Stoffwechsels∗

  2014cites this paper
• Vascular Function Intervention Trial in sickle cell disease (V-FIT): Trial Protocol

  2014cites this paper
• L-Arginine and vascular diseases: lights and pitfalls!

  2014cites this paper
• Vasoactifs artériels

  2014cites this paper
• Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling

  2014cites this paper
• The measurement, biological variation and response to acute inflammation of asymmetric dimethylarginine (ADMA)

  2013cites this paper
• L-Arginine Supplementation and Nitric Oxide Production: No Additional Effect When Associated to Exercise

  2013cites this paper
• Chapter 19 – Medical Treatment of Peripheral Artery Disease

  2013cites this paper
• Prostanoids for intermittent claudication.

  2013cites this paper
• Blood-CNS transport mechanisms in pathophysiology and drug delivery

  2013cites this paper
• Intermittent Claudication: New Targets for Drug Development

  2013influential citation
• A PILOT STUDY OF

  2013cites this paper
• Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects

  2012cites this paper
• Cardiovascular disease: primary prevention, disease modulation and regenerative therapy

  2012cites this paper
• Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication.

  2012influential citation
• Drug Treatment of Intermittent Claudication

  2012cites this paper
• Clinical Investigations The L-ArginineeAsymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy

  2012cites this paper
• Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients.

  2012cites this paper
• Tetrahydrobiopterin, L-Arginine and Vitamin C Act Synergistically to Decrease Oxidant Stress and Increase Nitric Oxide That Increases Blood Flow Recovery after Hindlimb Ischemia in the Rat

  2012cites this paper
• Die Hämodynamik drei Wochen alter Lämmer nach intrauteriner Anlage eines aortopulmonalen Shunts und lebenslanger Gabe von L-Arginin

  2012cites this paper
• OralL-argininesupplementationinpatients withmildarterialhypertensionanditseffecton plasmalevelofasymmetricdimethylarginine, L-citrulline,L-arginineandantioxidantstatus

  2012cites this paper
• Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.

  2012cites this paper
• Development of an Enzyme-Linked Immunosorbent Assay System for the Determination of Asymmetric Dimethylarginine Using a Specific Monoclonal Antibody

  2012cites this paper
• Exercise training and peripheral arterial disease.

  2012cites this paper
• The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.

  2012cites this paper
• Tetrahydrobiopterin, L-Arginine and Vitamin C Act Synergistically to Decrease Oxidative Stress, Increase Nitric Oxide and Improve Blood Flow after Induction of Hindlimb Ischemia in the Rat

  2012cites this paper
• Therapeutic strategies targeting endothelial function in humans: clinical implications.

  2012cites this paper
• OCENA SKUTECZNO ŚCI I BEZPIECZE ŃSTWA DWUMIESIĘCZNEJ DOUSTNEJ SUPLEMENTACJI L-ARGININ Ą U CHORYCH Z MIA śDśYCOWYM NIEDOKRWIENIEM KO ŃCZYN DOLNYCH W ZALE śNO ŚCI OD RODZAJU ZABURZE Ń GOSPODARKI LIPIDOWEJ

  2012cites this paper
• The relationship between L-arginine/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate.

  2012cites this paper
• Medical Therapy for Chronic Refractory Angina

  2012cites this paper
• Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status.

  2012cites this paper
• Medical management of the patient with intermittent claudication.

  2011cites this paper
• Phosphodiesterases as targets for intermittent claudication.

  2011cites this paper
• Nitric Oxide in the Development of Vascular Diseases and Regenerative Angiogenesis

  2011cites this paper
• L-Arginine as a Potential Ergogenic Aidin Healthy Subjects

  2011influential citation
• Medical Management of the Patient with Intermittent

  2011cites this paper
• Nitric Oxide–Asymmetric Dimethylarginine System in Endothelial Cell Senescence

  2010cites this paper
• Elevated Levels of Asymmetric Dimethylarginine in Chronic Heart Failure: A Pathophysiologic Link Between Oxygen Radical Load and Impaired Vasodilator Capacity and the Therapeutic Effect of Allopurinol

  2010cites this paper
• Pharmacotherapy for Symptoms of Intermittent Claudication

  2010cites this paper
• Intravitreal l-Arginine injection reverses the retinal arteriolar vasoconstriction that occurs after experimental acute branch retinal vein occlusion.

  2010cites this paper
• Lower Extremity Arterial Disease

  2010cites this paper
• Effect of L-arginine Oral Supplementation on Response to Myocardial Infarction in Hypercholesterolemic and Hypertensive Rats

  2010cites this paper
• The do’s and don’ts of arginine supplementation

  2010cites this paper
• Nitric Oxide in Vascular Damage and Regeneration

  2010cites this paper
• Acute L-arginine supplementation reduces the O2 cost of moderate-intensity exercise and enhances high-intensity exercise tolerance.

  2010cites this paper
• Acute L-arginine supplementation reduces the

  2010cites this paper
• The female runner: gender specifics.

  2010cites this paper
• Review Article: L-Arginine as a Nutritional Prophylaxis Against Vascular Endothelial Dysfunction With Aging

  2010cites this paper
• Procédés et compositions pour réduire le stress oxydatif

  2010cites this paper
• L-Arginine 経口摂取による前腕浴時の足趾表在温上昇への効果

  2009cites this paper
• Treatment strategies for peripheral artery disease

  2009cites this paper
• Capítulo 29 – Vasculopatía periférica

  2009cites this paper
• Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.

  2009cites this paper
• The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance.

  2009cites this paper
• Obesity and cardiovascular dysfunction: A role for resveratrol?

  2009cites this paper
• Pharmacologic Therapy for Intermittent Claudication

  2009cites this paper
• Novel markers of peripheral arterial disease

  2009cites this paper
• The Role of Nitric Oxide Synthase Inhibition by Asymmetric Dimethylarginine in the Pathophysiology of Preeclampsia

  2009cites this paper
• Suplementação proteica não aumenta a concentração plasmática de óxido nítrico em homens saudáveis

  2009cites this paper
• Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.

  2009cites this paper
• Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals.

  2008cites this paper
• Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency.

  2008cites this paper
• Current State of Medical Therapies for Peripheral Vascular Disease

  2008cites this paper
• A Laser doppler study of the effect of 2-alkylthio-4-ethyl-4-methyl-4,5 dihydro-1H-imidazolin-5-one oxime (oxime) on the ischaemic rat lower limb

  2008cites this paper
• Peripheral artery disease: therapeutic advances

  2008cites this paper
• A randomized trial of iloprost in patients with intermittent claudication

  2008cites this paper
• Asymmetrisches Dimethylarginin (ADMA): Ein kardiovaskulärer Risikofaktor

  2008cites this paper
• FARKLI ETYOLOJİK BEYİN DAMAR HASTALIĞI ALT TİPLERİNDE SERUM ADMA VE HOMOSİSTEİN DÜZEYLERİNİN KLİNİK VE İNFARKT BÜYÜKLÜĞÜNE OLAN ETKİSİNİN ARAŞTIRILMASI

  2008cites this paper